Structure of compound 34

oral PARP1-selective polymerase inhibitor

oral efficacy in BRCA1 mutant xenograft

from scaffold hopping from lit. PARP1/2 inh.

Bioorg. Med. Chem., Oct. 6, 2020

Lupin Ltd., Pune, IN

“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.